CN Patent

CN110433291A — 稳定的艾菲康唑组合物

Assigned to Bausch Health Ireland Ltd · Expires 2019-11-12 · 7y expired

What this patent protects

本发明提供含有艾菲康唑、丁羟甲苯、乙二胺四乙酸盐和任选的柠檬酸的组合物。该组合物表现出稳定的颜色外观，并且在真菌感染的治疗中是有用的。

USPTO Abstract

本发明提供含有艾菲康唑、丁羟甲苯、乙二胺四乙酸盐和任选的柠檬酸的组合物。该组合物表现出稳定的颜色外观，并且在真菌感染的治疗中是有用的。

Drugs covered by this patent

Patent Metadata

Patent number
CN110433291A
Jurisdiction
CN
Classification
—
Expires
2019-11-12
Drug substance claim
No
Drug product claim
No
Assignee
Bausch Health Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.